Day: May 3, 2021
VANCOUVER, British Columbia, May 03, 2021 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”) is pleased to provide the following corporate update.
We are extremely pleased to report that even though the Covid-19 pandemic continues to impact numerous business operations and even society itself, our enterprise has not only survived, but we are also thriving and growing.
With the early adoption of workplace anti-viral protocols in-place, we are proud to report that there have been no cases of Covid-19 at our facility despite our proximity to Whistler Village which has been hard hit by the pandemic. We sincerely offer our best wishes and thanks to our frontline workers across the nation and our thoughts are with all who have felt the impact of this awful disease....
AXIM Biotechnologies Introduces Diagnostics to Measure Immunity Against Emerging SARS-CoV-2 Variants
Written by Customer Service on . Posted in Public Companies.
SAN DIEGO, May 03, 2021 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announced today a new ELISA test that measures levels of neutralizing antibodies against six common variants of SARS-CoV-2 virus. The Company has also filed for patent protection for the diagnostic test.
SARS-CoV-2 variants from Brazil, South Africa, California and Britain have been shown to be more infectious and potentially more deadly than the original Wuhan strain due to mutations in the viral spike protein. This has caused concern because current COVID-19 vaccines are based on the spike protein in the Wuhan strain and it is not known how well the vaccines protect against the other variants.
AXIM Biotechnologies...
CytoDyn HIV Indication Update: Leronlimab HIV Extension Arm Nearing 7 Years with Continued Excellent Safety Results
Written by Customer Service on . Posted in Public Companies.
Following the successful conclusion of three clinical trials, approximately 120 patients continue treatment with leronlimab in extension arms
VANCOUVER, Washington, May 03, 2021 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (Vyrologix™ or PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today a comprehensive update on three continuing extension studies with leronlimab as a treatment for HIV.
Chris Recknor, M.D., CytoDyn’s Chief Operating Officer, commented, “We are still on schedule for rolling submission of the HIV BLA in July of this year. Clinical results from multiple trials show that Vyrologix can significantly reduce the viral burden in people infected with HIV. Moreover, a Phase 2 clinical...
Total Cray Valley and Gevo to further Scale Up Development of Renewable Isoamylene from Fusel Oil
Written by Customer Service on . Posted in Public Companies.
ENGLEWOOD, Colo., May 03, 2021 (GLOBE NEWSWIRE) — Total Cray Valley and Gevo, Inc. (NASDAQ: GEVO) announced today the successful completion of phase 1 of their Joint Development Agreement (JDA) to upgrade fusel oils into renewable isoamylene. The companies are now seeking to advance to Phase 2 of the JDA, which will allow for scale up of Gevo’s technology at a demonstration scale.
Fusel oils, made during the production of ethanol, equate to approximately 1 million tons of bio-based feedstock. The JDA, signed in 2020, is based on Gevo’s chemical-based catalytic processes that selectively convert low-value fusel oils, a mixture of alcohols that are byproducts from fermentation processes such as ethanol or isobutanol production, into higher-value renewable chemicals such as isoprene, ketones, aldehydes, or olefins, in this case isoamylene.
Isoamylene...
Generex Biotechnology Subsidiary Olaregen Therapeutix Announces Agreement with Nexgen Medical for Distribution of Excellagen® Wound Conforming Matrix in Malaysia
Written by Customer Service on . Posted in Public Companies.
MIRAMAR, Fla., May 03, 2021 (GLOBE NEWSWIRE) — Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) subsidiary Olaregen Therapeutix today announced that the company has executed a Distribution Agreement with Nexgen Medical Sdn Bhd, Inc. (“Nexgen”) to be Generex’s exclusive distributor to import, market and sell the Excellagen line of wound care products in Malaysia. Nexgen is coordinating the approval of Excellagen with the Malaysian Ministry of Health and expects commercial approval by the end of May 2021. Nexgen has committed to purchasing 1,000 units of Excellagen in year one, with an initial purchase of 500 units 0.8cc syringes of Excellagen.
Anthony J. Dolisi, President and Chief Executive Officer of Olaregen said, “This is an exciting day for Excellagen, as we have opened the door for international distribution...
Community West Bancshares Earnings Up 88% to $3.0 Million, or $0.35 Per Diluted Share, in 1Q21 Compared to 1Q20; Increases Quarterly Cash Dividend by 17% to $0.07 Per Common Share
Written by Customer Service on . Posted in Public Companies.
GOLETA, Calif., May 03, 2021 (GLOBE NEWSWIRE) — Community West Bancshares (Community West or the Company), (NASDAQ: CWBC), parent company of Community West Bank (the “Bank”), today reported net income increased 15.4% to $3.0 million, or $0.35 per diluted share, for the first quarter of 2021 (1Q21), compared to $2.6 million, or $0.31 per diluted share, for the fourth quarter of 2020 (4Q20), and increased 87.5% compared to $1.6 million, or $0.19 per diluted share, for the first quarter of 2020 (1Q20).
“We started the year with solid operating performance, higher net interest income and an expanding net interest margin, fueled by loan originations and core deposit growth,” stated Martin E. Plourd, President and Chief Executive Officer. “We continue to generate profitable operations, which sustains our ability to increase dividends....
Klövern makes an add-on acquisition in New York
Written by Customer Service on . Posted in Public Companies.
Klövern has acquired and taken possession of a property in Manhattan with the address 407 Park Avenue. The transaction’s underlying property value amounts to USD 30 million. The acquired property is located right next to Klövern’s planned future project on 417 Park Avenue which is developed in collaboration with the New York-based property developer GDSNY. This add-on acquisition further improves the development opportunities for that project.
Klövern AB (publ)For further information, please contact:Jens Andersson, Head of Finance, +46 76 855 67 02, jens.andersson@klovern.se Peeter Kinnunen, Acting CEO, +46 76 855 67 03, peeter.kinnunen@klovern.se Lars Norrby, IR, +46 76 777 38 00, lars.norrby@klovern.se
Klövern is a real estate company committed to working closely with customers to offer them attractive premises in growth regions. Klövern...
RESEARCH FRONTIERS TO HOST FIRST QUARTER 2021 CONFERENCE CALL
Written by Customer Service on . Posted in Public Companies.
WOODBURY, NY, May 03, 2021 (GLOBE NEWSWIRE) — Research Frontiers Inc. (Nasdaq: REFR) announced today that it will release its first quarter 2021 financial results on Thursday, May 6, 2021. Research Frontiers will host a conference call at 4:30 p.m. Eastern Time on Thursday, May 6, 2021 to discuss its first quarter 2021 financial and operating results as well as recent developments.Who: Joseph M. Harary, President & CEO
Date/Time: Thursday, May 6, 2021, 4:30 PM ET
Dial-in Information: 1-888-334-5785
Questions: Email to Questions@SmartGlass.com
Replay: Available on Friday, May 7, 2021 for 90 days at https://smartglass-ir.com/About Research Frontiers
Research Frontiers (Nasdaq: REFR) is a publicly traded technology company and the developer of patented SPD-Smart light-control film technology which allows users to instantly,...
International Land Alliance Signs Letter of Intent to Acquire Minority Interest in Rancho Costa Verde Development, LLC
Written by Customer Service on . Posted in Public Companies.
SAN DIEGO, CALIFORNIA, May 03, 2021 (GLOBE NEWSWIRE) — International Land Alliance, Inc. (OTCQB:ILAL), (“ILA” or the “Company”), an international land investment and development firm, has signed a Letter of Intent (the “LOI”) to acquire a 25% interest in Rancho Costa Verde Development, LLC (“RCV”). RCV is a profitable developer of a 1,100-acre, 1,200-lot master planned community in Baja California, located roughly 8 km north of ILA’s Oasis Park Resort.
“A key part of our growth strategy is making synergistic acquisitions that carry expanded resources to our operations, and this proposed agreement is an ideal example of meeting these criteria,” said Jason Sunstein, Vice President of ILA. “Not only is RCV an established, profitable development company with a complementary real estate asset, but its management team has sold...
GRAY TO ACQUIRE MEREDITH CORPORATION’S LOCAL MEDIA GROUP IN A $2.7 BILLION TRANSACTION
Written by Customer Service on . Posted in Public Companies.
Addition of Meredith’s 17 TV Stations Will Transform Gray into the Second Largest Television Broadcast GroupGray’s Pro Forma Television PortfolioPortfolio MapAtlanta, Ga., May 03, 2021 (GLOBE NEWSWIRE) — Gray Television, Inc. (“Gray”) (NYSE: GTN) has agreed to acquire all outstanding shares of Meredith Corporation (“Meredith”) for approximately $14.50 per share in cash, or $2.7 billion in total enterprise value after the spin off of Meredith’s National Media Group to the current Meredith shareholders. The parties expect to close the transaction in the fourth quarter of 2021.
Immediately prior to closing this acquisition, Meredith will spin off to its existing shareholders its National Media Group operating division, which owns the nation’s largest portfolio of magazines as well as digital and marketing assets....